All Doug Ingram articles

Article

Amid FDA turmoil Sarepta’s gene therapy worries begin to ease

2025-08-01T15:51:51Z

But the impact of George Tidmarsh’s CBER appointment after Vinay Prasad’s abrupt resignation remains to be seen.